PMBJX
Price
$44.34
Change
+$0.32 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
PSKCX
Price
$45.84
Change
+$0.21 (+0.46%)
Updated
Jul 25 closing price
Net Assets
1.03B
Interact to see
Advertisement

PMBJX vs PSKCX

Header iconPMBJX vs PSKCX Comparison
Open Charts PMBJX vs PSKCXBanner chart's image
Principal MidCap J
Price$44.34
Change+$0.32 (+0.73%)
VolumeN/A
Net Assets33.03B
Virtus KAR Mid-Cap Growth C
Price$45.84
Change+$0.21 (+0.46%)
VolumeN/A
Net Assets1.03B
PMBJX vs PSKCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMBJX vs. PSKCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBJX is a StrongBuy and PSKCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBJX has more cash in the bank: 33B vs. PSKCX (1.03B). PMBJX pays higher dividends than PSKCX: PMBJX (0.06) vs PSKCX (0.00). PMBJX was incepted earlier than PSKCX: PMBJX (24 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than PMBJX (0.78). PSKCX is a more actively managed with annual turnover of: 13.00 vs. PMBJX (10.50). PMBJX has a lower initial minimum investment than PSKCX: PMBJX (1000) vs PSKCX (2500). PMBJX annual gain was more profitable for investors over the last year : 13.47 vs. PSKCX (8.73). PMBJX return over 5 years is better than : 55.02 vs. PSKCX (9.22).
PMBJXPSKCXPMBJX / PSKCX
Total Expense Ratio0.782.0438%
Annual Report Gross Expense Ratio0.782.0438%
Fund Existence24 years25 years-
Gain YTD8.6503.453251%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets33B1.03B3,216%
Annual Yield % from dividends0.060.00-
Returns for 1 year13.478.73154%
Returns for 3 years48.8833.18147%
Returns for 5 years55.029.22597%
Returns for 10 years103.26140.7673%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHEPB6.300.12
+1.86%
Regional Health Properties, Inc.
AGRPF8.11N/A
N/A
Absa Group Ltd.
SAEYY12.45N/A
N/A
Redcare Pharmacy NV
BMKDF0.25N/A
N/A
Biomark Diagnostics Inc.
MLXEF0.40-0.03
-6.74%
Metals X, Ltd.